How often does Stoke Therapeutics move more than the options market prices?

1 of the last 8 reports moved at least as far as the implied move.

STOKNasdaqPharmaceutical Preparations

Stoke Therapeutics, Inc. (STOK) earnings date, market-implied expected move, and options open interest by expiry

27.15

+0.66 · +2.51%

Regular session15:26 ET

Open26.30Volume1.4MMkt cap$1.7BEPS-3.39

Day26.30 – 27.4673%52-wk20.32 – 40.2234%

STOK

Stoke Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Jan 11

before open · in 69 days

est.Q4 FY26

Calendar

Next report

Last report

−0.23%

vs ±10.1% implied · ×0.02

shaded = implied · ▲▼ = realized

Oct 29 '26 · confirmed

Implied vs realized

Linked news

5dBIIB · customerBiogen to Present New Data Across Alzheimer's Disease Portfolio at CTAD 2026

News

Largest filed tie

13F top-10 QoQ

+1.25%

shares held · 10 largest managers

13F · Jun 30 '26126d lag

198 managers

Top fund weight

0.48%

STOK weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Stoke Therapeutics (STOK) is expected to report on Jan 11 before open (estimated date).

Implied vs realized

8 reports

1 of 8≥ implied

avg implied: ±13.7%
avg realized: ±7.8%

Mar 18 '25Mar 18 '25confirmed±7.6%▼−1.44%×0.19

May 13 '25May 13 '25confirmed±11.8%▼−7.56%×0.64

Aug 12 '25Aug 12 '25confirmed±13.8%▲+24.98%×1.81

Nov 4 '25Nov 4 '25confirmed±22.6%▼−9.94%×0.44

Jan 12 '26Jan 12 '26confirmed±18.0%▼−10.44%×0.58

Q1 FY26May 7 '26confirmed±14.5%▲+0.30%×0.02

Q2 FY26Aug 3 '26confirmed±10.8%▲+7.14%×0.66

Oct 29 '26Oct 29 '26confirmed±10.1%▼−0.23%×0.02

quarterimplied−25%0+25%realized×

Oct '26±10.1%▼−0.23%×0.02

Q2 FY26±10.8%▲+7.14%×0.66

Q1 FY26±14.5%▲+0.30%×0.02

Jan '26±18.0%▼−10.44%×0.58

Nov '25±22.6%▼−9.94%×0.44

Aug '25±13.8%▲+24.98%×1.81

2 older reports

May '25±11.8%▼−7.56%×0.64

Mar '25±7.6%▼−1.44%×0.19

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 2 expiries · Oct 26 close

0.27OI · 2 expiries · Oct 26 closeP/C open interest · Feb 19 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

10,1740%Nov 2017d14.31711+1%14.31

report · Jan 11 · before open · est.

420%Feb 19108d1540%

ExpiryPutsCallsP/C

Nov 2017d10,1740%711+1%14.31

report · Jan 11 · before open · est.

Feb 19108d420%1540%0.27

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−660.78%as filednet margin · revenue +49.70% QoQ · −32.51% YoY

Revenue$9M+49.70%

Gross profit$9M100.00%+49.70%

Operating income−$65M−701.65%−22.48%

Pre-tax income−$62M−23.23%

Net income−$62M−660.78%−23.23%

Cost of revenue$0—

Operating expenses$75M+25.33%

Tax$0—

Other income$4M+11.60%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 15:15 ET

Intraday

Event sensitivity

FOMC ×1.12· ±3.7% vs ±3.3% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±3.7%14 of 24×1.12

PPIproducer prices±2.9%5 of 10×0.89

GDPgross domestic product±2.2%14 of 19×0.67

PCEpersonal income & outlays±2.0%9 of 19×0.61

CPIconsumer prices±1.6%3 of 10×0.49

CPROFcorporate profits±1.4%10 of 12×0.43

NFPjobs report±1.3%4 of 10×0.39

Bar = avg |move| to ±4% · tick = ±3.3% avg day · ×base = |move| ÷ ±3.3% · min 6 releases

Earnings history

EPS -0.93 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 3 '26 · confirmed	-0.93	—
Q1 FY26	May 7 '26 · confirmed	-0.79	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod